---

RECURRENT ABDOMINAL PAIN (RAP) IN CHILDREN

A Comprehensive Evidence-Based Review for MD/DNB Pediatrics Residents

---

SECTION 1: DEFINITION AND EVOLUTION OF TERMINOLOGY

1.1 Apley's Original Definition (1958)

"At least 3 episodes of abdominal pain, severe enough to affect activities, over a period of at least 3 months, in a child aged 4-14 years."

• Described the "Apley's triad" for psychogenic pain: child with anxious personality + family with similar complaints + stress at home/school
• Coined the concept that the pain is real but the cause is functional
• First noted the periumbilical localization as characteristic

• Did not distinguish subtypes of functional pain
• Grouped all non-organic pain together
• No pathophysiological basis provided

---

1.2 Evolution: From RAP to FAPDs

1.3 Current Terminology: Rome IV FAPDs (2016)

1. Functional Dyspepsia (FD)
2. Irritable Bowel Syndrome (IBS)
3. Abdominal Migraine (AM)
4. Functional Abdominal Pain - Not Otherwise Specified (FAP-NOS)

---

SECTION 2: EPIDEMIOLOGY AND BURDEN OF DISEASE

2.1 Prevalence

• Global pooled prevalence: ~1 in 9 children worldwide affected (Vermeijden, Pediatrics 2025)
• Gender: Equal incidence in boys and girls until age 9; after age 9, female:male ratio = 1.5:1; increases further after 12 years
• Peak age: Around 9 years; rare below 5 years
• Geography: Slightly higher in Asia (13%) vs. Europe (8.3%) vs. North America (7.7%)
• Under Rome IV criteria: FD becomes most prevalent (1 in 23), overtaking IBS (1 in 51) (Jeong, Gut Liver 2026)

2.2 Burden of Disease

• School absenteeism: Children with FAP achieve lower grades, related primarily to reduced attendance (Swanson's)
• Quality of life: Significant impairment in QoL for child and family
• Healthcare utilization: ~10% of children with abdominal pain seek medical evaluation; disproportionate healthcare costs
• Long-term outcomes: Risk of developing IBS, anxiety, and depression in adulthood
• Psychological morbidity: Anxiety, depression, stress, negative life events, and poor sleep are associated factors (Vermeijden, Pediatrics 2025)

---

SECTION 3: ETIOLOGY AND CLASSIFICATION

3.1 Overview: The 5% vs. 95% Rule

⭐ EXAM PEARL: Up to 90-95% of RAP in children is due to functional causes (FAPDs). Only 5-10% has an identifiable organic etiology. (PMID 40148656, Seetharaman, Indian J Pediatr 2025)

3.2 Functional Abdominal Pain Disorders (FAPDs)

3.3 Organic Causes

---

SECTION 4: PATHOPHYSIOLOGY OF FUNCTIONAL ABDOMINAL PAIN

4.1 The Brain-Gut Axis

┌─────────────────────────────────────────────────────┐
│                  BRAIN-GUT AXIS                      │
│                                                       │
│  Central Nervous System (Brain)                      │
│         ↕  (bidirectional via ANS/vagus/HPA)         │
│  Enteric Nervous System ("Second Brain" - 500M       │
│         neurons)                                     │
│         ↕                                            │
│  Gut Microbiome ←→ Mucosal Immune System            │
│         ↕                                            │
│  Visceral Afferents → Spinal cord → Brain            │
└─────────────────────────────────────────────────────┘

4.2 Visceral Hypersensitivity (Most Important Mechanism)

• Lowered pain threshold in the gut in response to normal stimuli (allodynia) or exaggerated response to painful stimuli (hyperalgesia)
• Mediated by sensitization of peripheral nociceptors and central sensitization
• Abnormal functioning of the autonomic nervous system results in altered intestinal motility and altered secretory pathways (Swanson's)
• Central enhancement of afferent visceral signals (Sleisenger & Fordtran)

4.3 Altered Motility

• Abnormal gut motility (either accelerated or delayed)
• Leads to abnormal distension, cramping
• Can be triggered by stress, infections (post-infectious IBS)

4.4 Altered Microbiome (Dysbiosis)

• Post-infectious alteration of gut microbiota
• Changed bacterial composition affects ENS function, mucosal immunity
• Mast cell activation in intestinal mucosa - key effector cell of the brain-gut axis (Yamada's Gastroenterology)
• Mast cell activation causes increased excitability of enteric neurons → visceral hypersensitivity (Yamada's)

4.5 Psychosocial Factors

• Stress activates HPA axis → CRF release → motility changes
• Anxiety, depression, school phobia, history of abuse
• Somatization: children learn to express emotional distress through physical symptoms
• Family reinforcement of pain behavior ("secondary gain")
• Strong association between stressful school events and RAP exacerbations

4.6 Post-Infectious Sensitization

• Acute gastroenteritis (especially Campylobacter, Salmonella) can trigger post-infectious IBS
• Altered epithelial barrier → increased mucosal permeability → persistent immune activation

Trigger (infection, stress, diet, life event)
          ↓
  Altered gut microbiome
  + Mucosal immune activation
  + Mast cell degranulation
          ↓
  Sensitized enteric neurons
          ↓
  ↑ Afferent visceral signals to brain
          ↓
  Central sensitization (dysregulated pain modulation)
  + Psychosocial amplification
          ↓
  VISCERAL HYPERSENSITIVITY + ALTERED MOTILITY
          ↓
  FUNCTIONAL ABDOMINAL PAIN

---

SECTION 5: HISTORY TAKING

5.1 Pain Characteristics (SOCRATES Mnemonic)

5.2 Important Positive Points in History

• Periumbilical, non-radiating
• Episodic (episodes of 1-3 hours duration)
• Associated with school days, stress, examinations
• Pallid appearance during attacks
• Family history of functional GI disorders, migraine, anxiety
• History of anxiety, school refusal, school phobia
• Headache/nausea accompanying attacks (abdominal migraine)
• Bowel habit changes related to pain onset (IBS)
• Prior episodes that resolved spontaneously

• Localized pain away from umbilicus (especially RLQ, RUQ, flank)
• Pain radiating to back, shoulder, groin
• Nocturnal pain awakening child from sleep
• Recurrent fever
• Weight loss, poor growth
• Blood in stool or urine
• Jaundice, hepatosplenomegaly
• Mouth ulcers, joint pain, rash (IBD/HSP)
• Dysuria, urgency, hematuria (UTI/stones)
• Cyclical pain correlating with menstruation (dysmenorrhea, endometriosis)
• Pain beginning <4 years of age

5.3 Important Negative Points (Features Favoring Functional)

• No fever
• No blood in stool/urine
• No weight loss/growth failure
• No nocturnal awakening
• No family history of IBD, celiac, stones
• Normal bowel habits (or only transiently altered)
• Pain is inconsistent in relation to meals and movement
• Patient "looks well" during and between episodes

5.4 Psychosocial History (MANDATORY)

• School performance and attendance
• Bullying, peer pressure, academic stress
• Home environment (parental discord, abuse)
• Recent stressful life events (bereavement, change of school)
• Parental anxiety about the child's symptoms
• Secondary gain from symptoms

---

SECTION 6: PHYSICAL EXAMINATION

6.1 General Examination

• Growth parameters: height, weight, BMI, growth velocity (vital - failure to thrive = organic cause)
• Pallor (anemia - IBD, celiac, hookworm)
• Jaundice (hepatobiliary disease)
• Lymphadenopathy
• Skin: rash (HSP/IgA vasculitis - palpable purpura), erythema nodosum (IBD), jaundice
• Perianal inspection: skin tags, fissures, fistulas (Crohn's disease)
• Mouth: aphthous ulcers (Crohn's), angular stomatitis (nutritional deficiency)

6.2 Abdominal Examination

6.3 Additional Examination

• Rectal examination: impaction, masses, blood on glove
• Genitourinary exam: in adolescent girls - pelvic exam if indicated
• Spine: scoliosis, vertebral tenderness
• Joints: arthritis (IBD-associated)

---

SECTION 7: RED FLAG (ALARM) SYMPTOMS AND SIGNS

7.1 "ALARM" Features Mnemonic

⭐ EXAM PEARL: Nocturnal pain that awakens a child from sleep is one of the most important red flags for organic disease. Functional pain rarely awakens a child from sleep.

⭐ EXAM PEARL: Alarm features increase the probability of organic etiology. However, the absence of alarm features supports (but does not confirm) a functional diagnosis.

---

SECTION 8: DIFFERENTIAL DIAGNOSIS BY AGE GROUP

⭐ EXAM PEARL: RAP is rare in children younger than 5 years, and an organic cause must be looked for more carefully in this age group. An organic cause must be vigorously investigated in a child presenting with functional pain symptoms under age 4.

---

SECTION 9: INVESTIGATIONS

9.1 Diagnostic Approach: When to Investigate

9.2 Initial/Basic Investigations (First-Line)

9.3 Targeted Investigations Based on Clinical Suspicion

9.4 Fecal Calprotectin (FCP) - High-Yield

⭐ EXAM PEARL: Fecal calprotectin is a highly sensitive tool to differentiate IBD from IBS/FAPDs. FCP >50-100 µg/g suggests intestinal inflammation (IBD); normal FCP strongly supports functional diagnosis and can avoid unnecessary endoscopy (Seetharaman, Indian J Pediatr 2025).

9.5 H. pylori Testing Recommendations (AAP/Red Book 2021)

• DO test: Children with identified peptic ulcer disease on endoscopy
• DO NOT test: Children with functional abdominal pain (absence of peptic ulcer disease); testing for H. pylori should not be performed when investigating functional abdominal pain (Red Book 2021)
• Preferred tests: Urea breath test or stool antigen test (avoid serology)

9.6 Imaging

9.7 Endoscopy

• Persistent/recurrent epigastric pain, hematemesis, dysphagia
• Suspected peptic ulcer, eosinophilic esophagitis, H. pylori
• Suspected celiac disease (duodenal biopsy)
• Iron deficiency anemia

• Hematochezia, unexplained anemia
• Suspected IBD (Crohn's, UC)
• Suspected colorectal polyps/cancer (family history)
• Fecal calprotectin elevated with no obvious cause

⭐ EXAM PEARL: Performing an upper GI endoscopy to "rule out all possibilities" in a child with typical FAP features and no alarm signs is NOT indicated as the next step. Basic workup (CBC, ESR, urinalysis) is appropriate first; endoscopy is reserved for specific indications.

---

SECTION 10: DIAGNOSTIC ALGORITHM FOR RAP IN CHILDREN

CHILD WITH RECURRENT ABDOMINAL PAIN
              ↓
DETAILED HISTORY + PHYSICAL EXAMINATION
              ↓
      ┌───────────────┐
      │ Alarm features│
      │ present?      │
      └───────────────┘
        /           \
      YES             NO
       ↓               ↓
TARGETED            REASSURE
INVESTIGATIONS      Limited initial workup:
(see Section 9.3)   CBC, ESR, CRP, UA+C,
       ↓            Stool OCP, Stool OB
SPECIFIC            Consider FCP if IBD
ORGANIC             suspected
DIAGNOSIS           ↓
       ↓        ALL NORMAL?
TREAT CAUSE         ↓ YES
                Apply Rome IV Criteria
                       ↓
              ┌─────────────────────┐
              │ Does pain meet      │
              │ criteria for:       │
              │ - FD?               │
              │ - IBS?              │
              │ - Abdominal         │
              │   Migraine?         │
              │ - FAP-NOS?          │
              └─────────────────────┘
                       ↓
              Positive diagnosis of FAPD
              (Do NOT call it "exclusion")
                       ↓
              MULTIMODAL MANAGEMENT
              (Reassurance + Dietary + Psychological
               + Pharmacological if needed)
                       ↓
              FOLLOW-UP AT 4-6 WEEKS
              (Monitor for emerging alarm features)

---

SECTION 11: FUNCTIONAL ABDOMINAL PAIN DISORDERS IN DETAIL

11.1 Functional Dyspepsia (FD)

1. One or more of:
   • Postprandial fullness (early satiety) interfering with meals
   • Epigastric pain or burning
   • Nausea
2. Symptoms not explained by another medical condition

• Pain/discomfort in epigastric region
• Postprandial distress syndrome (PDS): early satiety, postprandial fullness
• Epigastric pain syndrome (EPS): epigastric pain or burning
• May overlap
• Exclude peptic ulcer, GERD, H. pylori (treat H. pylori if found - do not assume FD until ulcer/H. pylori excluded)

---

11.2 Irritable Bowel Syndrome (IBS)

1. Abdominal pain associated with ≥2 of:
   • Related to defecation (pain improves OR worsens with defecation)
   • Change in stool frequency
   • Change in stool form (appearance)
2. In children with constipation, pain does not resolve with resolution of constipation (else functional constipation diagnosis)

• Most common FAPD subtype (5.8% globally)
• Post-infectious IBS: after acute gastroenteritis
• Lactose intolerance can mimic or co-exist
• Associated with anxiety, depression
• FODMAP foods can exacerbate

---

11.3 Abdominal Migraine (AM)

1. Paroxysmal episodes of intense, acute periumbilical, midabdominal, or diffuse abdominal pain lasting ≥1 hour
2. Episodes are stereotypical in individual patients
3. Pain is incapacitating and interferes with normal activities
4. Moderate to severe pain
5. Associated with ≥2 of:
   • Anorexia
   • Nausea
   • Vomiting
   • Headache
   • Photophobia
   • Pallor
6. Not attributed to another condition

• Free intervals between attacks (completely symptom-free)
• Often family history of migraine
• Personal history of motion sickness
• Part of the "childhood periodic syndromes" (precursor to migraine)
• Cyclic vomiting syndrome is a related entity
• Treatment: pizotifen, propranolol (prophylaxis); acute: sumatriptan (older children), rest in dark/quiet room
• Link to migraine: evidence of frequent co-occurrence of abdominal episodes with headache (Adams & Victor, 12th Ed)

⭐ EXAM PEARL: Abdominal migraine is not a diagnosis of exclusion - it has specific Rome IV positive criteria. The key feature is episodic, stereotypical, severe periumbilical pain with complete symptom-free intervals and associated autonomic features (pallor, nausea, photophobia).

---

11.4 Functional Abdominal Pain - Not Otherwise Specified (FAP-NOS)

1. Episodic or continuous abdominal pain
2. Insufficient criteria for IBS, FD, or AM
3. No evidence of inflammatory, anatomic, metabolic, or neoplastic process to explain symptoms

• Previously called "functional abdominal pain" or "recurrent abdominal pain" (Apley-type)
• Periumbilical pain, episodic, non-radiating
• FAP-NOS with somatization: recurrent abdominal pain + additional somatic symptoms (headache, limb pain, fatigue) = functional abdominal pain syndrome
• School-age children, peak 9 years
• Strong association with school phobia, anxiety, parental anxiety
• Least common subtype under Rome IV criteria (1.2%)

---

SECTION 12: MANAGEMENT

12.1 General Principles

---

12.2 Reassurance and Counseling (FIRST-LINE for all FAPDs)

• Provide positive diagnosis of FAPD (not "we found nothing wrong")
• Explain the brain-gut axis in age-appropriate terms ("sensitive gut" model)
• Acknowledge the pain is real, not imagined
• Address parental anxiety - avoid excessive medical investigations
• Encourage normal activities including school attendance
• Set realistic expectations: symptoms may persist but are not dangerous
• Identify and address psychosocial stressors

Evidence: Reassurance alone significantly reduces symptoms in 30-40% of children with FAP (Swanson's)

---

12.3 Dietary Modifications

---

12.4 Psychological Therapies (STRONGEST EVIDENCE)

⭐ HIGH-YIELD EXAM POINT (2025 Landmark Meta-Analysis): The Lancet Child & Adolescent Health 2025 network meta-analysis (91 RCTs, 7,226 children) found hypnotherapy and CBT are the only two treatments with moderate certainty evidence for treatment success in pediatric AP-DGBIs. All other treatments (pharmacological, probiotic, dietary) had very low certainty evidence. (PMID 40246358, Sinopoulou et al.)

---

12.5 Pharmacological Treatment

⭐ EXAM PEARL - IMPORTANT: Amitriptyline, despite widespread use, failed to show superiority over placebo in RCTs for functional abdominal pain in children (PMID 38972964). This is a frequently asked viva question.

AVOID: Narcotic analgesics (opioids) - do NOT use for functional abdominal pain; can cause narcotic bowel syndrome and dependence. NSAIDs should also be avoided for functional pain.

---

12.6 Management of Common Organic Causes

---

SECTION 13: FOLLOW-UP AND PROGNOSIS

13.1 Follow-up Schedule

• Initial follow-up: 4-6 weeks after diagnosis
• Reassess symptoms, screen for emerging alarm features
• Reinforce reassurance and therapeutic plan
• Avoid repeating unnecessary investigations unless new alarm signs emerge

13.2 Prognosis

⭐ EXAM PEARL - PARADIGM SHIFT: Contrary to the old teaching that "children naturally outgrow FAP," current evidence shows that children with FAP do NOT simply outgrow it - many develop IBS and significant psychological issues in adulthood, profoundly impacting quality of life and educational outcomes. (Rajindrajith et al., Eur J Pediatr 2024 - PMID 38972964)

---

SECTION 14: RECENT ADVANCES AND CURRENT RECOMMENDATIONS

---

SECTION 15: FREQUENTLY ASKED MD/DNB EXAMINATION QUESTIONS

15.1 Short Answer/Essay Questions

1. Define RAP and explain the evolution from Apley's criteria to Rome IV criteria.
2. Classify the causes of RAP in children. What percentage is functional?
3. What are the red flag features in RAP? How do they help in differentiating organic from functional pain?
4. Describe the Rome IV criteria for functional dyspepsia, IBS, abdominal migraine, and FAP-NOS in children.
5. Outline the management of functional abdominal pain in children.
6. What is the brain-gut axis? How does it contribute to functional abdominal pain?
7. When would you perform an upper GI endoscopy in a child with RAP?
8. What is the role of fecal calprotectin in the evaluation of RAP?
9. Discuss the role of psychological therapies in FAP. Which has the best evidence?
10. What is the prognosis of RAP in children?

15.2 Viva Voice Questions

---

SECTION 16: HIGH-YIELD EXAM TABLES AND MNEMONICS

16.1 Mnemonic for Organic Causes: "CHAMP GIN"

• C - Constipation, Celiac, Crohn's
• H - H. pylori, HSP, Hepatitis
• A - Appendicitis (chronic), Adhesions, Anatomical anomalies (malrotation)
• M - Mesenteric adenitis, Meckel's, Metabolic
• P - Pancreatitis, PUD, Porphyria
• G - Gynecological (dysmenorrhea, ovarian cyst), Giardiasis
• I - Infections (parasites, TB, UTI), IBD
• N - Nephrolithiasis, Neurological (abdominal epilepsy)

16.2 Mnemonic for Red Flags: "RFLAGS"

• R - Rectal bleeding; Radiation of pain
• F - Fever (unexplained); Family history (IBD, celiac)
• L - Localized pain (away from umbilicus); Loss of weight
• A - Age <4-5 years; Arthritis
• G - Growth failure; Guarding (peritonism)
• S - Sleep disturbance (nocturnal pain); Skin/perianal changes

16.3 Key Comparison Table: Organic vs. Functional Pain

16.4 Rome IV Criteria Summary Table

---

SECTION 17: SUMMARY FOR EXAM REVISION

Core Points to Remember

1. RAP = ≥3 episodes/3 months (Apley's) but today we use Rome IV FAPD criteria for positive diagnosis
2. 90-95% of RAP is functional (FAPD); only 5-10% organic
3. IBS is the most common FAPD subtype (Rome III); FD becomes most prevalent under stricter Rome IV criteria
4. Global prevalence ~11% (meta-analyses 2025-2026); higher in girls, higher in Asia
5. Red flags = organic disease - especially nocturnal pain, localized pain, rectal bleeding, growth failure, fever
6. FAP onset <4-5 years - must investigate for organic cause
7. Periumbilical location is characteristic of functional pain
8. Rome IV positive criteria - diagnose FAPDs positively, not by exclusion
9. Fecal calprotectin - first-line biomarker to triage for endoscopy; differentiates IBD from IBS
10. H. pylori - do NOT test in functional abdominal pain (AAP/Red Book)
11. Hypnotherapy + CBT = best evidence for treatment (Lancet 2025 meta-analysis, moderate certainty)
12. Amitriptyline = no better than placebo in pediatric FAP (important viva point)
13. Children do NOT simply outgrow FAP - risk of adult IBS and psychological morbidity persists
14. Rome V (2026) - expanded upper GI DGBIs with precision diagnostics
15. FODMAP moderation (not strict elimination) - current recommendation for children

Quick Recall: 4 FAPDs + Rome IV Minimum Duration

FD → 2 months (epigastric)
IBS → 2 months, 4 days/month (bowel related)
AM → 2 episodes/6 months (severe periumbilical, episodic)
FAP-NOS → 2 months, 4 episodes/month (periumbilical, no criteria for others)

---

• Apley J, Naish N. Recurrent abdominal pains: a field survey of 1,000 school children. Arch Dis Child. 1958.
• AAP/NASPGHAN Clinical Report on Chronic Abdominal Pain, 2005 (Pediatrics).
• Rome IV Diagnostic Criteria for FGIDs/DGBIs, 2016. Gastroenterology.
• Vermeijden NK et al. Epidemiology of Pediatric FAPDs: A Meta-Analysis. Pediatrics. 2025. (PMID 39761807)
• Jeong YD et al. Global Prevalence of FAPD - Rome III and IV. Gut Liver. 2026. (PMID 40852741)
• Sinopoulou V et al. Efficacy of interventions for AP-DGBIs in children - Network Meta-Analysis. Lancet Child Adolesc Health. 2025. (PMID 40246358)
• Rajindrajith S et al. 65 years of insights on FAP in children. Eur J Pediatr. 2024. (PMID 38972964)
• Vandenplas Y et al. Multidisciplinary expert consensus on FAPDs. Front Pediatr. 2025. (PMID 40433476)
• Seetharaman J. RAP in a Child - Evaluation and Management. Indian J Pediatr. 2025. (PMID 40148656)
• Rosen R et al. Rome V Pediatric Upper GI DGBIs. Gastroenterology. 2026. (PMID 41713704)
• Red Book 2021. AAP Committee on Infectious Diseases. H. pylori in Children.
• Sleisenger & Fordtran's Gastrointestinal and Liver Disease (10th ed).
• Nelson Textbook of Pediatrics (21st ed).
• Swanson's Family Medicine Review (problem-oriented approach).

---

NOTE ON EVIDENCE STRENGTH:

• Strong evidence: Hypnotherapy and CBT for FAPDs (Lancet 2025 - moderate certainty from RCTs)
• Moderate evidence: Low-FODMAP diet (short-term), peppermint oil, probiotics (L. reuteri, L. rhamnosus), cyproheptadine
• Weak/no evidence: Amitriptyline (no better than placebo in RCTs), most pharmacological agents for FAP
• Emerging: Rome V precision diagnostics, digital therapies, PERCUSS, gut microbiome-targeted interventions